rs7187889

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBA1

The NM_000512.5(GALNS):​c.599C>T​(p.Thr200Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00787 in 1,613,198 control chromosomes in the GnomAD database, including 842 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. T200T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.041 ( 447 hom., cov: 33)
Exomes 𝑓: 0.0044 ( 395 hom. )

Consequence

GALNS
NM_000512.5 missense

Scores

2
9
6

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 9.48

Publications

8 publications found
Variant links:
Genes affected
GALNS (HGNC:4122): (galactosamine (N-acetyl)-6-sulfatase) This gene encodes N-acetylgalactosamine-6-sulfatase which is a lysosomal exohydrolase required for the degradation of the glycosaminoglycans, keratan sulfate, and chondroitin 6-sulfate. Sequence alterations including point, missense and nonsense mutations, as well as those that affect splicing, result in a deficiency of this enzyme. Deficiencies of this enzyme lead to Morquio A syndrome, a lysosomal storage disorder. [provided by RefSeq, Jul 2008]
GALNS Gene-Disease associations (from GenCC):
  • mucopolysaccharidosis type 4A
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

PM1
In a hotspot region, there are 7 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 5 uncertain in NM_000512.5
BP4
Computational evidence support a benign effect (MetaRNN=0.0019369423).
BP6
Variant 16-88836235-G-A is Benign according to our data. Variant chr16-88836235-G-A is described in ClinVar as Benign. ClinVar VariationId is 198087.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.141 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000512.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GALNS
NM_000512.5
MANE Select
c.599C>Tp.Thr200Met
missense
Exon 6 of 14NP_000503.1P34059
GALNS
NM_001323544.2
c.617C>Tp.Thr206Met
missense
Exon 7 of 15NP_001310473.1
GALNS
NM_001323543.2
c.44C>Tp.Thr15Met
missense
Exon 5 of 13NP_001310472.1Q6YL38

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GALNS
ENST00000268695.10
TSL:1 MANE Select
c.599C>Tp.Thr200Met
missense
Exon 6 of 14ENSP00000268695.5P34059
GALNS
ENST00000562593.5
TSL:1
n.4008C>T
non_coding_transcript_exon
Exon 4 of 12
GALNS
ENST00000862787.1
c.710C>Tp.Thr237Met
missense
Exon 7 of 15ENSP00000532846.1

Frequencies

GnomAD3 genomes
AF:
0.0413
AC:
6288
AN:
152196
Hom.:
445
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.144
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0158
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000413
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000558
Gnomad OTH
AF:
0.0272
GnomAD2 exomes
AF:
0.0109
AC:
2720
AN:
250494
AF XY:
0.00799
show subpopulations
Gnomad AFR exome
AF:
0.147
Gnomad AMR exome
AF:
0.00738
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000450
Gnomad OTH exome
AF:
0.00604
GnomAD4 exome
AF:
0.00437
AC:
6388
AN:
1460884
Hom.:
395
Cov.:
32
AF XY:
0.00382
AC XY:
2773
AN XY:
726774
show subpopulations
African (AFR)
AF:
0.152
AC:
5074
AN:
33412
American (AMR)
AF:
0.00846
AC:
378
AN:
44696
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26126
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.000278
AC:
24
AN:
86232
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52888
Middle Eastern (MID)
AF:
0.00625
AC:
36
AN:
5764
European-Non Finnish (NFE)
AF:
0.000293
AC:
326
AN:
1111694
Other (OTH)
AF:
0.00909
AC:
549
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
303
606
908
1211
1514
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
158
316
474
632
790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0414
AC:
6307
AN:
152314
Hom.:
447
Cov.:
33
AF XY:
0.0396
AC XY:
2946
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.144
AC:
5970
AN:
41540
American (AMR)
AF:
0.0158
AC:
242
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5194
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000544
AC:
37
AN:
68034
Other (OTH)
AF:
0.0269
AC:
57
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
289
579
868
1158
1447
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0110
Hom.:
146
Bravo
AF:
0.0478
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.146
AC:
643
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.0134
AC:
1628
Asia WGS
AF:
0.00520
AC:
18
AN:
3478
EpiCase
AF:
0.000491
EpiControl
AF:
0.000593

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not specified (4)
-
-
3
Mucopolysaccharidosis, MPS-IV-A (3)
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Uncertain
0.050
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Pathogenic
0.82
D
Eigen
Uncertain
0.22
Eigen_PC
Uncertain
0.29
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.92
D
MetaRNN
Benign
0.0019
T
MetaSVM
Benign
-0.64
T
MutationAssessor
Benign
1.3
L
PhyloP100
9.5
PrimateAI
Uncertain
0.57
T
PROVEAN
Uncertain
-2.8
D
REVEL
Uncertain
0.46
Sift
Uncertain
0.027
D
Sift4G
Benign
0.089
T
Polyphen
0.93
P
Vest4
0.26
MPC
0.23
ClinPred
0.053
T
GERP RS
5.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.47
gMVP
0.75
Mutation Taster
=26/74
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7187889; hg19: chr16-88902643; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.